English | Español
Amanda Rupp | Aug 22, 2016

EMD Serono earns CEO Cancer Gold Standard re-accreditation
Amanda Rupp | Aug 22, 2016

Survey demonstrates support for U.S. precision medicine study
Amanda Rupp | Aug 22, 2016

FDA moves forward with BASE inhibitor for Alzheimer’s patients
Amanda Rupp | Aug 22, 2016

Surgery useful for treating myasthenia gravis
Amanda Rupp | Aug 21, 2016

Protein target found for ALS
Amanda Rupp | Aug 21, 2016

Update released on state legislation to decrease cancer presence
Amanda Rupp | Aug 21, 2016

NORD releases statement about PDUFA VI commitment letter
Amanda Rupp | Aug 21, 2016

Epilepsy Foundation releases two medical grants

Trending
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards